| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 17 |
| 1 | METHOTREXATE | 14 |
| 2 | ETOPOSIDE | 12 |
| 3 | CYCLOPHOSPHAMIDE | 10 |
| 4 | CYCLOPHOSPHAMIDE FOR INJECTION | 10 |
| 5 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 10 |
| 6 | CISPLATIN | 9 |
| 7 | ADALIMUMAB | 6 |
| 8 | FLUDARABINE PHOSPHATE | 5 |
| 9 | RITUXIMAB | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DACTINOMYCIN | 2 | 0.0009 |
| 1 | MIFEPRISTONE | 1 | 0.0002 |
| 2 | MISOPROSTOL | 2 | 0.0002 |
| 3 | BLEOMYCIN SULFATE | 2 | 0.0002 |
| 4 | HYDROXYUREA | 4 | 0.0002 |
| 5 | ETOPOSIDE | 12 | 0.0002 |
| 6 | FLUDARABINE PHOSPHATE | 5 | 0.0001 |
| 7 | CISPLATIN | 9 | 0.0001 |
| 8 | CLADRIBINE | 1 | 0.0001 |
| 9 | ADALIMUMAB-FKJP | 4 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 1 | Topoisomerase Inhibitor [EPC] | 12 |
| 2 | Alkylating Drug [EPC] | 10 |
| 3 | Platinum-based Drug [EPC] | 9 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 5 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 5 |
| 6 | Antimetabolite [EPC] | 4 |
| 7 | Actinomycin [EPC] | 2 |
| 8 | Microtubule Inhibitor [EPC] | 2 |
| 9 | Prostaglandin E1 Analog [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 2 | 0.0009 |
| 1 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 2 | Topoisomerase Inhibitor [EPC] | 12 | 0.0002 |
| 3 | Prostaglandin E1 Analog [EPC] | 2 | 0.0001 |
| 4 | Alkylating Drug [EPC] | 10 | 0.0000 |
| 5 | Platinum-based Drug [EPC] | 9 | 0.0000 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 14 | 0.0000 |
| 7 | Copper-containing Intrauterine Device [EPC] | 1 | 0.0000 |
| 8 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 5 | 0.0000 |